Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 12K | $4.02M | $335.00 | Mar 5, 2025 | Direct |
MADRIGAL PHARMACEUTICALS, INC. | Chief Commercial Officer | Stock Option (Right to Buy) | 5.7K | Mar 5, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Mar 5, 2025 | 2 | $0 | 4 | Mar 7, 2025 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Mar 3, 2025 | 9 | -$598K | 4 | Mar 5, 2025 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 24, 2025 | 1 | -$116K | 4 | Jan 27, 2025 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 21, 2024 | 1 | -$218K | 4 | Nov 22, 2024 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 23, 2024 | 3 | $0 | 4 | Jan 25, 2024 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 20, 2023 | 2 | $0 | 4 | Nov 22, 2023 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 20, 2023 | 0 | $0 | 3 | Nov 22, 2023 | Chief Commercial Officer |